Published May 11, 2021
| Version v4
Journal article
Open
HOXB5 overexpression is associated with neuroendocrine differentiation and poor prognosis in prostate cancer
Authors/Creators
- 1. Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University
Description
Supplementary Table 1 Clinicopathologic characteristics of 128 PCa patients who were treated with radical prostatectomy.
Supplementary Table 2 Clinicopathologic characteristics of 74 with metastatic PCa with androgen deprivation therapy
Supplementary figure 1 The expression of HOXB5 from GSE147250 (A) HOXB5 expression in control, RB1 knockout, TP53 knockout, and double (RB1/TP53) knockout cells in LNCaP. KO: knockout, DKO: double knockout (B) HOXB5 expression in control, and double (RB1/TP53) knockout cells in LNCaP treated with enzalutamide. DKO: double knockout
Files
Supplementary compressed file re-submit.zip
Files
(77.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:60c2060267eeb50cdc3bb1d84a1a32a8
|
77.0 kB | Preview Download |